Patients with chronic hepatitis C achieving a sustained virological response to peginterferon and ribavirin therapy recover from impaired hepcidin secretion☆
To access this article, please choose from the options below
☆ The authors declare that they do not have anything to disclose regarding funding from industries or conflict of interest with respect to this manuscript.
PII: S0168-8278(08)00358-9
doi:10.1016/j.jhep.2008.05.014
© 2008 European Association for the Study of the Liver. Published by Elsevier Inc. All rights reserved.
